What does Intrepid Labs do?
Intrepid Labs is a biotechnology company based in Toronto that leverages artificial intelligence and robotics to improve drug formulation development. Its flagship Valiant platform uses modular, AI-driven robotic systems to automate and refine the drug formulation process, while the company is also developing proprietary oral and long-acting injectable delivery technologies for both small molecules and biologics.
How much did they raise?
The company raised $7M USD in a Seed funding round led by AVANT BIO, with participation from Radical Ventures and Propagator Ventures. This follows an earlier $4M USD unannounced pre-seed round.
What are their plans for the money?
With the new funding, Intrepid Labs plans to expand its team, accelerate the development of its proprietary drug delivery technologies, and scale its commercial operations. This move is expected to enhance the efficiency of drug development by offering advanced, automated solutions in formulation design.
What have they achieved so far?
Intrepid Labs has already demonstrated the capabilities of its Valiant platform, which is utilized by industry partners to optimize drug formulations. The company’s previous successful pre-seed funding round further underscores its potential to innovate in drug development.
